Health Insurance (Section 3C Pathology Services—ALK Gene Testing) Amendment Determination 2018 (Cth)

Health Insurance (Section 3C Pathology Services—ALK Gene Testing) Amendment Determination 2018

I, CELIA STREET, delegate of the Minister for Health, make this Determination under subsection 3C(1) of the Health Insurance Act 1973. 

Dated        14 February 2018

CELIA STREET

Assistant Secretary

Diagnostic Imaging and Pathology Branch

Medical Benefits Division

Department of Health

Contents

1.           Name of Determination

2.           Commencement

3.           Authority

4.           Amendment of the Health Insurance (ALK Gene Testing) Determination 2017

Schedule 1 – Amendments

1. Name of Determination

This Determination is the Health Insurance (Section 3C Pathology Services—ALK Gene Testing) Amendment Determination 2018.

1. Commencement

This Determination commences the day after registration.

1. Authority

This Determination is made under subsection 3C(1) of the Health Insurance Act 1973.

1. Amendment of the Health Insurance (ALK Gene Testing) Determination 2017

Schedule 1 amends the Health Insurance (ALK Gene Testing) Determination 2017

Schedule 1 – Amendments

1       Schedule 1 (item 73341, column headed “Service”)

Omit “crizotinib or ceritinib”, substitute “ crizotinib, ceritinib or alectinib”.